Infertility Treatment Market to Reach US$ 6.24 Billion by 2032, Growing at 10.6% CAGR Through 2025-2032 - Key Players: CooperSurgical, Vitrolife, FUJIFILM Irvine Scientific

The Global Infertility Treatment Market reached US$ 2.78 billion in 2024 and is expected to reach US$ 6.24 billion by 2032, growing at a CAGR of 10.6% during the forecast period 2025-2032. The market is witnessing strong growth due to rising infertility rates among both men and women, increasing prevalence of lifestyle-related conditions, delayed parenthood, and growing social acceptance of assisted reproductive technologies (ART).

Infertility treatment includes a wide range of therapeutic approaches such as fertility drugs, in vitro fertilization (IVF), intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI), and assisted reproductive procedures. Continuous advancements in reproductive technologies, improved success rates of fertility procedures, and expanding access to fertility clinics are supporting market expansion. Additionally, increasing investments in reproductive healthcare, favorable reimbursement policies in certain regions, and the growing role of personalized and hormone-based therapies are further accelerating adoption and shaping the future of infertility care globally.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/infertility-treatment-market?sai-v

The Infertility Treatment Market is the sector that provides medical therapies, assisted reproductive technologies, and services to help individuals and couples achieve pregnancy.

Key Developments
✅ December 2025: Advances in assisted reproductive technologies (ART), including AI-supported embryo selection and improved cryopreservation techniques, enhanced IVF success rates.

✅ October 2025: Growing adoption of personalized infertility treatment protocols based on genetic testing, hormonal profiling, and lifestyle factors improved patient outcomes.

✅ August 2025: Expansion of fertility clinics and cross-border reproductive care increased access to advanced infertility treatments in emerging and developed markets.

✅ June 2025: Increased awareness and acceptance of infertility treatments, supported by employer fertility benefits and insurance coverage, drove higher treatment uptake.

✅ March 2025: Ongoing clinical research in novel hormonal therapies and minimally invasive fertility procedures strengthened the infertility treatment pipeline.

Mergers & Acquisitions
✅ December 2025: A major healthcare or fertility services provider acquired a network of fertility clinics to expand its infertility treatment footprint and service offerings.

✅ October 2025: Strategic partnerships were formed between fertility treatment companies and digital health platforms to enhance patient engagement and remote care support.

✅ August 2025: Fertility clinics collaborated with diagnostic and genetic testing companies to integrate advanced screening into treatment pathways.

✅ June 2025: Pharmaceutical companies entered alliances with fertility centers to support development and distribution of fertility drugs and hormonal therapies.

✅ March 2025: Academic institutions and early-stage biotech startups partnered to advance reproductive medicine research and next-generation infertility treatment solutions.

Key Players
CooperSurgical Inc. | Vitrolife | FUJIFILM Irvine Scientific, Inc. | Genea Limited | IVFtech ApS | Kitazato Corporation | Rocket Medical plc | Gynemed GmbH (Gynemedia) | Boston IVF | Aspire Fertility

Key Highlights

CooperSurgical Inc. - Holds a share of 18.6%: A leading provider of IVF and assisted reproductive technology (ART) solutions, offering comprehensive consumables, instruments, and genetic testing products for fertility clinics.

Vitrolife - Holds a share of 16.9%: Specializes in advanced IVF culture media, cryopreservation solutions, and time-lapse embryo monitoring systems to improve implantation and pregnancy outcomes.

FUJIFILM Irvine Scientific, Inc. - Holds a share of 14.2%: Focuses on high-quality cell culture media and reagents supporting IVF, embryology, and reproductive medicine worldwide.

Genea Limited - Holds a share of 9.1%: Combines fertility clinic operations with advanced reproductive technologies, including embryo selection and genetic screening solutions.

IVFtech ApS - Holds a share of 6.8%: Provides specialized IVF laboratory equipment and consumables designed to enhance laboratory efficiency and embryo handling.

Kitazato Corporation - Holds a share of 11.3%: Known for cryopreservation and vitrification technologies widely used in IVF clinics for embryo and oocyte preservation.

Rocket Medical plc - Holds a share of 5.4%: Supplies medical devices and consumables for gynecology and fertility procedures, supporting assisted reproduction workflows.

Gynemed GmbH (Gynemedia) - Holds a share of 6.2%: Develops embryo culture media and fertility lab products focused on optimizing embryo development.

Boston IVF - Holds a share of 6.0%: One of the largest fertility clinic networks, contributing clinical expertise, innovation, and patient-centered ART services.

Aspire Fertility - Holds a share of 5.5%: Operates a network of advanced fertility clinics offering IVF, fertility preservation, and reproductive health services.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=infertility-treatment-market?sai-v
(Purchase 2 or more Reports and get 50% discount)

Market Drivers
- Rising prevalence of infertility due to lifestyle changes, stress, obesity, and delayed parenthood.

- Growing awareness and acceptance of assisted reproductive technologies and fertility treatments.

- Advancements in in vitro fertilization, intracytoplasmic sperm injection, and cryopreservation techniques.

- Rising maternal age and declining fertility rates in developed and developing countries.

- Increasing healthcare expenditure and expanding fertility clinics worldwide.

- Supportive government initiatives and improving insurance coverage for fertility treatments in some regions.

Industry Developments
- Advancements in IVF technologies, including time-lapse imaging and genetic screening.

- Expansion of fertility preservation services such as egg and sperm freezing.

- Growing adoption of minimally invasive and personalized fertility treatment approaches.

- Increasing collaborations between fertility clinics, pharmaceutical companies, and diagnostic providers.

- Integration of AI and data analytics to improve embryo selection and treatment success rates.

- Rising investments, mergers, and acquisitions in fertility treatment centers and technology providers.

- Development of new fertility drugs and hormone therapies.

Regional Insights
North America - 38% share: Driven by high awareness, advanced fertility clinics, and strong adoption of assisted reproductive technologies.

Europe - 31% share: Supported by favorable regulations in several countries, public funding support, and established reproductive healthcare systems.

Asia Pacific - 26% share: Fueled by large patient population, rising infertility rates, increasing disposable income, and growing medical tourism.

Latin America - 3% share: Boosted by expanding private fertility clinics and improving access to reproductive healthcare.

Middle East & Africa - 2% share: Driven by rising demand for fertility services, healthcare infrastructure development, and cultural shifts toward treatment adoption.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/infertility-treatment-market?sai-v

Key Segments

➥ By Procedure
Assisted Reproductive Technology (ART): Advanced fertility treatments involving medical procedures to address infertility by handling eggs, sperm, or embryos outside the human body.

In Vitro Fertilization (IVF): A widely used ART procedure where fertilization occurs outside the body, followed by embryo transfer into the uterus.

Intracytoplasmic Sperm Injection (ICSI): A specialized IVF technique involving direct injection of a single sperm into an egg to overcome male infertility factors.

Intracytoplasmic Morphologically Selected Sperm Injection (IMSI): An advanced form of ICSI using high-magnification microscopy to select morphologically superior sperm.

Gamete Donation: Use of donor sperm, eggs, or embryos to assist individuals or couples facing infertility challenges.

Surrogacy: Arrangement where a surrogate carries and delivers a child on behalf of intended parents.

Artificial Insemination: Fertility treatment involving direct placement of sperm into the female reproductive tract.

Intrauterine Insemination (IUI): Placement of sperm directly into the uterus to improve chances of fertilization.

Intracervical Insemination: Introduction of sperm into the cervix, often used in less invasive fertility treatments.

Intratubal Insemination: Placement of sperm or eggs directly into the fallopian tubes to facilitate fertilization.

Fertility Surgeries: Surgical interventions aimed at correcting anatomical or physiological causes of infertility.

Laparoscopy: Minimally invasive surgery used to diagnose and treat reproductive disorders such as endometriosis or tubal blockages.

Hysteroscopy: Procedure to examine and treat abnormalities inside the uterus affecting fertility.

Myomectomy: Surgical removal of uterine fibroids to improve fertility outcomes.

Laparotomy: Open surgical procedure used for complex fertility-related conditions.

Tubal Ligation Reversal: Surgery to restore fertility after previous sterilization procedures.

Varicocelectomy: Surgical correction of varicoceles to improve male fertility.

Microsurgical Reconstruction: Precision surgery to restore reproductive tract function.

Vasovasostomy: Microsurgical reconnection of the vas deferens following vasectomy.

Vasoepididymostomy: Advanced microsurgery to bypass blockages in the epididymis and restore sperm flow.

Other Infertility Treatment Procedures: Includes emerging and adjunct procedures used to enhance fertility outcomes.

➥ By Product
Equipment: Core medical equipment used in fertility clinics and ART laboratories to support diagnostic and treatment procedures.

Microscopes: High-precision microscopes used for sperm, egg, and embryo assessment and micromanipulation.

Imaging Systems: Systems used for visualization and monitoring of reproductive organs, embryos, and procedural accuracy.

Sperm Analyzer Systems: Devices used to evaluate sperm count, motility, morphology, and overall quality.

Ovum Aspiration Pumps: Equipment used for safe and controlled egg retrieval during IVF procedures.

Micromanipulator Systems: Precision tools used in ICSI and IMSI for handling sperm and eggs.

Incubators: Controlled environments that support embryo development by maintaining optimal temperature, humidity, and gas levels.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.